175 related articles for article (PubMed ID: 24981454)
21. mTORC1 and mTORC2 regulate insulin secretion through Akt in INS-1 cells.
Le Bacquer O; Queniat G; Gmyr V; Kerr-Conte J; Lefebvre B; Pattou F
J Endocrinol; 2013 Jan; 216(1):21-9. PubMed ID: 23092880
[TBL] [Abstract][Full Text] [Related]
22. Deletion of Rictor in catecholaminergic neurons alters locomotor activity and ingestive behavior.
Kaska S; Brunk R; Bali V; Kechner M; Mazei-Robison MS
Neuropharmacology; 2017 May; 117():158-170. PubMed ID: 28167137
[TBL] [Abstract][Full Text] [Related]
23. Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma.
Zhang X; Wang X; Xu T; Zhong S; Shen Z
Tumour Biol; 2015 Jul; 36(7):5273-81. PubMed ID: 25666752
[TBL] [Abstract][Full Text] [Related]
24. Cardiac mTOR complex 2 preserves ventricular function in pressure-overload hypertrophy.
Shende P; Xu L; Morandi C; Pentassuglia L; Heim P; Lebboukh S; Berthonneche C; Pedrazzini T; Kaufmann BA; Hall MN; Rüegg MA; Brink M
Cardiovasc Res; 2016 Jan; 109(1):103-14. PubMed ID: 26598511
[TBL] [Abstract][Full Text] [Related]
25. Early TCR alpha beta expression promotes maturation of T cells expressing Fc epsilon RI gamma containing TCR/CD3 complexes.
Petersson K; Ivars F
J Immunol; 2001 Jun; 166(11):6616-24. PubMed ID: 11359815
[TBL] [Abstract][Full Text] [Related]
26. Opposite ability of pre-TCR and alpha beta TCR to induce apoptosis.
Steff AM; Trop S; Maira M; Drouin J; Hugo P
J Immunol; 2001 Apr; 166(8):5044-50. PubMed ID: 11290785
[TBL] [Abstract][Full Text] [Related]
27. Early growth response gene 3 regulates thymocyte proliferation during the transition from CD4-CD8- to CD4+CD8+.
Xi H; Kersh GJ
J Immunol; 2004 Jan; 172(2):964-71. PubMed ID: 14707069
[TBL] [Abstract][Full Text] [Related]
28. The mTORC2 complex regulates terminal differentiation of C2C12 myoblasts.
Shu L; Houghton PJ
Mol Cell Biol; 2009 Sep; 29(17):4691-700. PubMed ID: 19564418
[TBL] [Abstract][Full Text] [Related]
29. Defective thymocyte maturation by transgenic expression of a truncated form of the T lymphocyte adapter molecule and Fyn substrate, Sin.
Donlin LT; Roman CA; Adlam M; Regelmann AG; Alexandropoulos K
J Immunol; 2002 Dec; 169(12):6900-9. PubMed ID: 12471123
[TBL] [Abstract][Full Text] [Related]
30. Down regulation of Peroxiredoxin-3 in 3T3-L1 adipocytes leads to oxidation of Rictor in the mammalian-target of rapamycin complex 2 (mTORC2).
Olson DH; Burrill JS; Kuzmicic J; Hahn WS; Park JM; Kim DH; Bernlohr DA
Biochem Biophys Res Commun; 2017 Nov; 493(3):1311-1317. PubMed ID: 28986255
[TBL] [Abstract][Full Text] [Related]
31. Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology.
Thomanetz V; Angliker N; Cloëtta D; Lustenberger RM; Schweighauser M; Oliveri F; Suzuki N; Rüegg MA
J Cell Biol; 2013 Apr; 201(2):293-308. PubMed ID: 23569215
[TBL] [Abstract][Full Text] [Related]
32. Involvement of Rictor/mTORC2 in cardiomyocyte differentiation of mouse embryonic stem cells
Zheng B; Wang J; Tang L; Tan C; Zhao Z; Xiao Y; Ge R; Zhu D
Int J Biol Sci; 2017; 13(1):110-121. PubMed ID: 28123351
[TBL] [Abstract][Full Text] [Related]
33. Rictor regulates cell migration by suppressing RhoGDI2.
Agarwal NK; Chen CH; Cho H; Boulbès DR; Spooner E; Sarbassov DD
Oncogene; 2013 May; 32(20):2521-6. PubMed ID: 22777355
[TBL] [Abstract][Full Text] [Related]
34. Conditional astroglial Rictor overexpression induces malignant glioma in mice.
Bashir T; Cloninger C; Artinian N; Anderson L; Bernath A; Holmes B; Benavides-Serrato A; Sabha N; Nishimura RN; Guha A; Gera J
PLoS One; 2012; 7(10):e47741. PubMed ID: 23077666
[TBL] [Abstract][Full Text] [Related]
35. Rictor Undergoes Glycogen Synthase Kinase 3 (GSK3)-dependent, FBXW7-mediated Ubiquitination and Proteasomal Degradation.
Koo J; Wu X; Mao Z; Khuri FR; Sun SY
J Biol Chem; 2015 May; 290(22):14120-9. PubMed ID: 25897075
[TBL] [Abstract][Full Text] [Related]
36. mTORC2 regulates multiple aspects of NKT-cell development and function.
Sklarz T; Guan P; Gohil M; Cotton RM; Ge MQ; Haczku A; Das R; Jordan MS
Eur J Immunol; 2017 Mar; 47(3):516-526. PubMed ID: 28078715
[TBL] [Abstract][Full Text] [Related]
37. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
[TBL] [Abstract][Full Text] [Related]
38. PRR5, a novel component of mTOR complex 2, regulates platelet-derived growth factor receptor beta expression and signaling.
Woo SY; Kim DH; Jun CB; Kim YM; Haar EV; Lee SI; Hegg JW; Bandhakavi S; Griffin TJ; Kim DH
J Biol Chem; 2007 Aug; 282(35):25604-12. PubMed ID: 17599906
[TBL] [Abstract][Full Text] [Related]
39. Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide.
Festuccia WT; Pouliot P; Bakan I; Sabatini DM; Laplante M
PLoS One; 2014; 9(4):e95432. PubMed ID: 24740015
[TBL] [Abstract][Full Text] [Related]
40. The Bardet-Biedl syndrome-related protein CCDC28B modulates mTORC2 function and interacts with SIN1 to control cilia length independently of the mTOR complex.
Cardenas-Rodriguez M; Irigoín F; Osborn DP; Gascue C; Katsanis N; Beales PL; Badano JL
Hum Mol Genet; 2013 Oct; 22(20):4031-42. PubMed ID: 23727834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]